4//SEC Filing
GRAY WILLIAM GARRETT 4
Accession 0001104659-22-010998
CIK 0001651407other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 7:01 PM ET
Size
7.3 KB
Accession
0001104659-22-010998
Insider Transaction Report
Form 4
GRAY WILLIAM GARRETT
Chief Financial Officer
Transactions
- Sale
COMMON STOCK
2022-02-01$2.51/sh−37,063$92,954→ 582,107 total - Award
COMMON STOCK (RESTRICTED)
2022-01-31+137,000→ 619,170 total
Footnotes (4)
- [F1]The shares of restricted stock vest as follows: one-fourth on January 31, 2023, one-fourth on January 31, 2024, one-fourth on January 31, 2025 and one-fourth on January 31, 2026
- [F2]Includes shares of restricted Common Stock, which vest over various time periods
- [F3]In connection with the vesting of 72,750 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F4]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.50 to $2.55. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Checkpoint Therapeutics, Inc.
CIK 0001651407
Entity typeother
Related Parties
1- filerCIK 0001692961
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 7:01 PM ET
- Size
- 7.3 KB